Why Did InnoCare Pharma (SEHK:9969) Move Today?

Simply Wall St.10-18

InnoCare Pharma (SEHK:9969) is back on investors’ radar after three orelabrutinib studies were picked for oral presentation at JSH 2026, highlighting real-world and Phase II blood cancer data. Despite...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment